10 Stocks Making Headlines Today
US equity market is in the red on Wednesday despite stronger-than-anticipated results from the US manufacturing sector.
Blueprint Medicines Corp (BPMC)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Cadian Capital Eric Bannasch | 1,921,347 | $122,736 | +327% | 6.12% |
| 2. | Casdin Capital Eli Casdin | 1,550,000 | $99,014 | 4.43% | |
| 3. | Farallon Capital Thomas Steyer | 1,356,987 | $86,684 | +68% | 0.46% |
| 4. | Alkeon Capital Management Panayotis Takis Sparaggis | 1,143,899 | $73,072 | -11% | 0.14% |
| 5. | Rock Springs Capital Management Kris Jenner, Gordon Bussard, Graham Mcphail | 947,715 | $60,540 | +11% | 1.52% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $59.98 | 5,000 | 10,812 | 2022-03-03 | Filing | ||
| $18.00 | 125,000 | Large Shareholder, Other | 2,500,711 | 2015-05-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $59.76 | 1,908 | 28,685 | 2022-06-06 | Filing | ||
| $60.00 | 3,155 | 27,296 | 2022-06-07 | Filing | ||
| $59.76 | 1,220 | 30,451 | 2022-06-06 | Filing | ||
| $56.21 | 12,758 | 183,243 | 2022-05-16 | Filing | ||
| $55.63 | 5,342 | 196,001 | 2022-05-16 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 239,976 | $15,329,667 | 0% | |
| 2. | 43,387 | $2,771,561 | 0.02% | |
| 3. | 16,000 | $1,022,000 | 0.02% | |
| 4. | 8,468 | $540,936 | 0% | |
| 5. | 5,525,060 | $352,941 | 0% |
News See All
Were Hedge Funds Right About Blueprint Medicines Corporation (BPMC)?
Stocks, especially the once high flying technology stocks, had a lousy start to the new year. QQQ lost 9% of its value in January.
Should I Avoid Blueprint Medicines Corporation (BPMC)?
A whopping number of 13F filings filed with U.S.
5 New Stock Picks of Billionaire Ken Fisher
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is a biotech firm that develops therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases.
Eric Bannasch’s Cadian Capital Portfolio: 10 Biggest Stock Picks
In this article, we discuss the 10 biggest stock picks in Eric Bannasch's portfolio.
Blueprint Medicines Corporation (BPMC): Hedge Funds Are Snapping Up
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of every quarter.
Should I Avoid Blueprint Medicines Corporation (BPMC)?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
10 Best Pharmaceutical Stocks to Buy According to Billionaire Kerr Neilson
In this article we will take a look at the 10 best pharmaceutical stocks to buy according to billionaire Kerr Neilson.
Is BPMC Stock A Buy or Sell?
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
15 Fastest Growing Biotech Companies in the US
Biotechnology is one of the most consequential domains of the healthcare industry.
Billionaire Hedge Funds
